TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30942150

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (1.5 ml L-1) plus gibberellin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (4.5 ml L-1) under optimum water level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (4.5 ml L-1) plus gibberellin under severe water stress
Number of subjects: 0
Study: 28402237

Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold
Number of subjects: 1845

Group type: COMPARATOR
Intervention: Metallic stent
Number of subjects: 1845
Study: 25886152

Group type: EXPERIMENTAL
Intervention: Olive Oil
Number of subjects: 831

Group type: COMPARATOR
Intervention: HOFA
Number of subjects: 831
Study: 23962028

Group type: EXPERIMENTAL
Intervention: Everolimus (EVE) + Exemestane (EXE)
Number of subjects: 724

Group type: COMPARATOR
Intervention: Placebo (PBO) + Exemestane (EXE)
Number of subjects: 724
Study: 21200342

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo-IMT
Number of subjects: 25
Study: 19519260

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 17244316

Group type: EXPERIMENTAL
Intervention: Chrysalin (TP508) applied topically, twice weekly
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (placebo) applied topically, twice weekly
Number of subjects: 60
Study: 14703471

Group type: EXPERIMENTAL
Intervention: IgY solution
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 10737482

Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 1229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1229
Study: 8912445

Group type: EXPERIMENTAL
Intervention: Prostakath (first-generation stent)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: ProstaCoil (second-generation stent)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Both stents
Number of subjects: 117
Study: 1424192

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy for 3 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 2869618

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical therapy (coronary artery bypass surgery)
Number of subjects: 0
Study: 30670251

Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: HT Sham
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control with aide (CP)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control without aide (CNP)
Number of subjects: 39
Study: 27827397

Group type: EXPERIMENTAL
Intervention: high-MC-SFA supplementation
Number of subjects: 52

Group type: COMPARATOR
Intervention: low-MC-SFA butter
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: high-MC-SFA butter
Number of subjects: 52
Study: 25776110

Group type: EXPERIMENTAL
Intervention: Moms and Teens for Safe Dates program (six mailed booklets of dating abuse prevention information and interactive activities)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Moms and Teens for Safe Dates program
Number of subjects: 409
Study: 23312562

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behavior therapy (8-week program)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Pretreatment Clinician Administered PTSD Scale severity
Number of subjects: 55
Study: 21035202

Group type: EXPERIMENTAL
Intervention: Young adults (mean age: 20)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Older adults (mean age: 77)
Number of subjects: 53
Study: 19948642

Group type: EXPERIMENTAL
Intervention: Screening for diabetes (negative test result)
Number of subjects: 5334

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 5334
Study: 17276100

Group type: EXPERIMENTAL
Intervention: Graduated elastic compression stockings for one week
Number of subjects: 300

Group type: COMPARATOR
Intervention: Graduated elastic compression stockings for three weeks
Number of subjects: 300
Study: 15542294

Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 181

Group type: COMPARATOR
Intervention: Coronary balloon angioplasty
Number of subjects: 181
Study: 11832846

Group type: EXPERIMENTAL
Intervention: Support and information programme for lay caregivers
Number of subjects: 0
Study: 9793288

Group type: EXPERIMENTAL
Intervention: 1500 ppm fluoride dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-fluoride dentifrice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between 1500 ppm F dentifrice and non-fluoride dentifrice
Number of subjects: 0
Study: 7702230

Group type: EXPERIMENTAL
Intervention: Fluvastatin with alcohol (40 mg/d + 20 g ethanol diluted to 20% with orange juice)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fluvastatin alone (40 mg/d + orange juice)
Number of subjects: 31
Study: 2695556

Group type: EXPERIMENTAL
Intervention: Subconjunctival injections of clindamycin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oral pyrimethamine and sulfadiazine (P + S)
Number of subjects: 29
Study: 319642

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: P/D (Propranolol and Digoxin combination)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: P/D
Number of subjects: 30
Study: 31145387

Group type: EXPERIMENTAL
Intervention: Vertical training group (back-half-squat)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Horizontal training group (barbell hip-thrust)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (general strength training)
Number of subjects: 24
Study: 30232744

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt containing Lactobacillus acidophilus La5, Bifidobacterium BB12, and Lactobacillus casei DN001 (108 CFU/g each)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular yogurt
Number of subjects: 60
Study: 28281218

Group type: EXPERIMENTAL
Intervention: IDegLira
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin Glargine U100
Number of subjects: 0
Study: 25496176

Group type: COMPARATOR
Intervention: Heptavalent pneumococcal conjugate vaccine (PCV), administered to 52 children, monitored for 3 years.
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (unvaccinated children), monitored for 3 years.
Number of subjects: 109

Group type: COMPARATOR
Intervention: Heptavalent pneumococcal conjugate vaccine (PCV)
Number of subjects: 109
Study: 23175691

Group type: EXPERIMENTAL
Intervention: Metformin 1 g in the morning and 500 mg in the evening for 6 months
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 22090227

Group type: EXPERIMENTAL
Intervention: Intravascular hypothermia (group A, n = 20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Traditional cooling (group B, n = 21)
Number of subjects: 41
Study: 19917733

Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation combined with stretching exercises and foot orthoses
Number of subjects: 26

Group type: COMPARATOR
Intervention: Stretching exercises and foot orthoses (Control)
Number of subjects: 26
Study: 17086374

Group type: EXPERIMENTAL
Intervention: Lichtenstein hernioplasty for primary inguinal hernia
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Lichtenstein hernioplasty for recurrent inguinal hernia
Number of subjects: 362
Study: 12559241

Group type: EXPERIMENTAL
Intervention: Daily discrimination training task using an oddball paradigm with cutaneous electrical stimuli for 3 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 40
Study: 10594492

Group type: EXPERIMENTAL
Intervention: BEC-HFA (CFC-free inhaler with hydrofluoroalkane)
Number of subjects: 10

Group type: COMPARATOR
Intervention: BEC-CFC (CFC-based inhaler)
Number of subjects: 10
Study: 8697722

Group type: EXPERIMENTAL
Intervention: Endogenous lithium clearance (CLi)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exogenous lithium clearance (CLi) with 450 mg lithium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exogenous lithium clearance (CLi) with 600 mg lithium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fractional excretion of lithium (FELi) with endogenous lithium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fractional excretion of lithium (FELi) with 450 mg lithium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fractional excretion of lithium (FELi) with 600 mg lithium
Number of subjects: 12
Study: 12797080

Group type: EXPERIMENTAL
Intervention: Transabdominal chorionic villus sampling
Number of subjects: 3347

Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 3347

Group type: EXPERIMENTAL
Intervention: Transcervical chorionic villus sampling
Number of subjects: 3347
Study: 6982566

Group type: EXPERIMENTAL
Intervention: lonazolac-Ca (200 mg t.i.d.)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: diclofenac-Na (50 mg t.i.d.)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: indomethacin (50 mg t.i.d.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (during wash-out period)
Number of subjects: 6
Study: 3902682

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate cream
Number of subjects: 227

Group type: COMPARATOR
Intervention: 0.05% fluocinonide cream
Number of subjects: 227
Study: 29735021

Group type: EXPERIMENTAL
Intervention: Prednisolone 30 mg/day (PRED30; n=12)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Prednisolone 7.5 mg/day (PRED7.5; n=12)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n=8)
Number of subjects: 32
Study: 27723699

Group type: EXPERIMENTAL
Intervention: Ademetionin 400 mg 2 times a day for 7 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Remaxol 400 ml once a day for 7 days
Number of subjects: 100
Study: 24575806

Group type: EXPERIMENTAL
Intervention: Thickened extensive casein hydrolysate (T‐eCH)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nonthickened extensive casein hydrolysate (NT‐eCH)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both T‐eCH and NT‐eCH
Number of subjects: 72
Study: 22622786

Group type: EXPERIMENTAL
Intervention: Ultrathin prototype colonoscope
Number of subjects: 187

Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 187
Study: 20619382

Group type: COMPARATOR
Intervention: HCV E1E2 vaccine adjuvanted with MF59, administered at 3 different dosages on day 0 and weeks 4, 24, and 48.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HCV E1E2 vaccine adjuvanted with MF59.
Number of subjects: 0
Study: 18584523

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 15798007

Group type: EXPERIMENTAL
Intervention: 3-month intervention
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: 9-month intervention
Number of subjects: 154
Study: 12708964

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 2x900 mg doses
Number of subjects: 18

Group type: COMPARATOR
Intervention: Methionine loading without NAC (Met group)
Number of subjects: 18
Study: 10574809

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (deferred treatment)
Number of subjects: 121
Study: 8923816

Group type: EXPERIMENTAL
Intervention: Responses produced certain action effects: tones on the left versus the right or tones of low versus high pitch.
Number of subjects: 0
Study: 1994609

Group type: EXPERIMENTAL
Intervention: Colonoscopy in persons with positive Hemoccult‐II tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screen-detected adenomas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Symptoms related to adenomas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperplastic polyps
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopic polypectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical removal
Number of subjects: 0
Study: 6978687

Group type: EXPERIMENTAL
Intervention: Electrolyte solution (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Blood from the pump‐oxygenator (Group B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comparison of Group A and Group B
Number of subjects: 40
Study: 31256674

Group type: EXPERIMENTAL
Intervention: VEPE liner
Number of subjects: 89

Group type: COMPARATOR
Intervention: ModXLPE liner
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: VEPE and ModXLPE
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Patients with radiolucency
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: PTC shells
Number of subjects: 89
Study: 29893003

Group type: EXPERIMENTAL
Intervention: ipragliflozin 50 mg
Number of subjects: 124

Group type: COMPARATOR
Intervention: sitagliptin
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: ipragliflozin
Number of subjects: 124
Study: 26643400

Group type: EXPERIMENTAL
Intervention: Psycho-educational programme (PEP)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 86
Study: 24100783

Group type: EXPERIMENTAL
Intervention: Accelerated diagnostic protocol (Thrombolysis in Myocardial Infarction score, 0; electrocardiography; and 0- and 2-hour troponin tests)
Number of subjects: 542

Group type: COMPARATOR
Intervention: Standard-care pathway (troponin test on arrival, prolonged observation, and a second troponin test 6-12 hours after onset of pain)
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 542
Study: 23023840

Group type: EXPERIMENTAL
Intervention: Medication Therapy Management (MTM) intervention
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Enhanced MTM
Number of subjects: 637

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 637
Study: 19943165

Group type: EXPERIMENTAL
Intervention: 100 mg/day ASA
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: 100 mg/day ASA and 75 mg/day clopidogrel
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (no anti-platelet medication)
Number of subjects: 186
Study: 18440727

Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 240

Group type: COMPARATOR
Intervention: cRT
Number of subjects: 240
Study: 16003270

Group type: EXPERIMENTAL
Intervention: Strain rate (SR) imaging
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (normal values)
Number of subjects: 77
Study: 11812696

Group type: EXPERIMENTAL
Intervention: Selective spinal anesthesia (SSA) with lidocaine 10 mg + sufentanil 10 microg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Desflurane anesthesia (DES) and N(2)O
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Selective spinal anesthesia (SSA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Desflurane anesthesia (DES)
Number of subjects: 20
Study: 10098808

Group type: EXPERIMENTAL
Intervention: Training and a guide book
Number of subjects: 50

Group type: COMPARATOR
Intervention: Guide book only
Number of subjects: 50
Study: 8934059

Group type: EXPERIMENTAL
Intervention: Triphasic OC pill containing 35 mg ethinyl estradiol (EE) and 50 mg desogestrel (DSG) in the first seven tablets; 30 mg EE and 100 mg DSG in tablets 8 to 14, and 30 mg EE and 150 mg DSG in tablets 15 to 21
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: OC pills containing 20 mg EE plus 150 mg DSG (15 patients) or 75 mg of gestodene (14 patients)
Number of subjects: 51
Study: 1913714

Group type: EXPERIMENTAL
Intervention: Naloxone (0.2 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6358486

Group type: EXPERIMENTAL
Intervention: Psychological techniques for reducing dependence on hypnotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (users who did not receive psychological treatment)
Number of subjects: 0
Study: 29373687

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 213

Group type: COMPARATOR
Intervention: Stavudine
Number of subjects: 213
Study: 26497446

Group type: EXPERIMENTAL
Intervention: Implicit negative associations
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Explicit spider fear
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Implicit avoidance tendencies
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Working memory capacity (WMC)
Number of subjects: 63
Study: 25383780

Group type: EXPERIMENTAL
Intervention: Direct access to low-dose computed tomography (LDCT) combined with a Continuing Medical Education (CME) meeting on lung cancer diagnosis
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: CME participation
Number of subjects: 648

Group type: COMPARATOR
Intervention: Usual fast-track evaluation
Number of subjects: 648
Study: 21967845

Group type: EXPERIMENTAL
Intervention: EPA-DHA (400 mg/d)
Number of subjects: 2911

Group type: EXPERIMENTAL
Intervention: ALA (2 g/d)
Number of subjects: 2911

Group type: EXPERIMENTAL
Intervention: Both EPA-DHA and ALA
Number of subjects: 2911

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2911

Group type: EXPERIMENTAL
Intervention: EPA-DHA
Number of subjects: 2911

Group type: EXPERIMENTAL
Intervention: ALA
Number of subjects: 2911
Study: 21309493

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg orally 1 hour prior to HSG
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 17681958

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa weight-based dosing (0.75 mcg/kg every 2 weeks for 26 weeks)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa fixed dosing (50 mcg every 2 weeks for 26 weeks)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 16572737

Group type: EXPERIMENTAL
Intervention: High frequency oscillatory ventilation (HFOV)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Plasma sICAM-1 levels
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Plasma sICAM-1 on day 3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 16
Study: 12167135

Group type: EXPERIMENTAL
Intervention: Tizanidine (mean dose 18 mg, titrated to maximum 24 mg over 4 weeks)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Tizanidine
Number of subjects: 200
Study: 10210050

Group type: EXPERIMENTAL
Intervention: Tramadol 0.5 mg x kg(‐1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tramadol 0.25 mg x kg(‐1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal saline 0.05 ml x kg(‐1)
Number of subjects: 36
Study: 8590121

Group type: EXPERIMENTAL
Intervention: Continuous cold therapy (cold therapy pads placed over a thin dressing, maintained at 42 degrees F for the immediate postoperative period, used for an average of 3 days)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (identical operative and postoperative procedure without continuous cold therapy)
Number of subjects: 52
Study: 2709943

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: No prostaglandin E1 therapy (Control)
Number of subjects: 51
Study: 61854

Group type: EXPERIMENTAL
Intervention: EEG operant conditioning
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Scalp EMG suppression reinforcement
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control periods
Number of subjects: 5
Study: 31036412

Group type: EXPERIMENTAL
Intervention: Glucomannan (3 g/d for 12 weeks)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 3 g/d for 12 weeks)
Number of subjects: 96
Study: 27489077

Group type: EXPERIMENTAL
Intervention: Guided Internet-based cognitive behavioral therapy (ICBT) for 9 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Web-based moderated discussion forum (DF)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Guided Internet-based cognitive behavioral therapy (ICBT)
Number of subjects: 50
Study: 25097243

Group type: EXPERIMENTAL
Intervention: IOL (Intraocular Lens)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Contact Lens (CL)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both IOL and CL groups
Number of subjects: 103
Study: 23786339

Group type: EXPERIMENTAL
Intervention: High-dose oxytocin (4 mU/min, increasing every 30 minutes to 64 mU/min)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard-dose oxytocin (2 mU/min, increasing every 30 minutes to 32 mU/min)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: High-dose oxytocin
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard-dose oxytocin
Number of subjects: 94
Study: 19914604

Group type: EXPERIMENTAL
Intervention: L-DOPA (300 mg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 18381306

Group type: EXPERIMENTAL
Intervention: Arthroscopic Bankart repair
Number of subjects: 88
Study: 16323004

Group type: EXPERIMENTAL
Intervention: Binocular vision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monocular viewing (one eye occluded)
Number of subjects: 0
Study: 12727080

Group type: EXPERIMENTAL
Intervention: Azithromycin 4.5 g total for 3 weeks (1 x 500 mg weekly for 3 days)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg b.i.d. for 20 days
Number of subjects: 89
Study: 10811587

Group type: EXPERIMENTAL
Intervention: Gamma-irradiation (192Ir)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (dummy seeds)
Number of subjects: 38
Study: 9387566

Group type: EXPERIMENTAL
Intervention: Retinamide (20mg/kg orally every day for eight weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 7876035

Group type: EXPERIMENTAL
Intervention: Deceptive questions (D)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Honest questions (H)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Free-choice condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: No-choice condition
Number of subjects: 32
Study: 3411756

Group type: EXPERIMENTAL
Intervention: 20-session risk-reduction intervention
Number of subjects: 1447
Study: 31479006

Group type: EXPERIMENTAL
Intervention: High amount high intensity treadmill exercise (HAHI)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: High amount low intensity treadmill exercise (HALI)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Low amount low intensity treadmill exercise
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: All exercise groups
Number of subjects: 103